Assessing Anti-HCMV Cell Mediated Immune Responses in Transplant Recipients and Healthy Controls Using a Novel Functional Assay
Charlotte J. Houldcroft,
Sarah E. Jackson,
Eleanor Y. Lim,
George X. Sedikides,
Emma L. Davies,
Claire Atkinson,
Megan McIntosh,
Ester B. M. Remmerswaal,
Georgina Okecha,
Frederike J. Bemelman,
Richard J. Stanton,
Matthew Reeves,
Mark R. Wills
Jul 10, 2020
HCMV infection, reinfection or reactivation occurs in 60% of untreated solid organ transplant (SOT) recipients. Current clinical approaches to HCMV management include pre-emptive and prophylactic antiviral treatment strategies....